Clinical Trial Update: Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether varenicline upregulates dopamine D2/D3 receptors in methamphetamine users; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Dopamine D2/3 Receptor Availability, Cognitive Function | Phase 1 | Status: TERMINATED